Ovarian cancer Trials in St. Louis, United States
Conditions / Ovarian cancer / St. Louis, United States
Clinical trials for Ovarian cancer investigate a range of treatment strategies and patient populations.
99 total trials for this combination
Showing top 10 of 99 trials
Trials
| NCT ID | Title | Status | Phase |
|---|---|---|---|
| NCT06910657 | IDOV-Immune for Advanced Solid Tumors | RECRUITING | PHASE1 |
| NCT06051695 | A Study to Evaluate the Safety and Efficacy of Mesothelin-Targeting Logic-gated CAR T, in Participants With Solid Tumors That Express MSLN and Have Lost HLA-A*02 Expression | RECRUITING | PHASE1/PHASE2 |
| NCT02568267 | Basket Study of Entrectinib (RXDX-101) for the Treatment of Patients With Solid Tumors Harboring NTRK 1/2/3 (Trk A/B/C), ROS1, or ALK Gene Rearrangements (Fusions) | ACTIVE_NOT_RECRUITING | PHASE2 |
| NCT03452774 | SYNERGY-AI: Artificial Intelligence Based Precision Oncology Clinical Trial Matching and Registry | RECRUITING | — |
| NCT07038369 | A Phase 1 Study of ATV-1601 in Patients With Advanced Cancer That Have AKT1 E17K Mutations | ACTIVE_NOT_RECRUITING | PHASE1 |
| NCT03662204 | Blood Sample Collection to Evaluate Biomarkers in Subjects With Untreated Solid Tumors | COMPLETED | — |
| NCT04383210 | Study of Seribantumab in Adult Patients With NRG1 Gene Fusion Positive Advanced Solid Tumors | TERMINATED | PHASE2 |
| NCT06257264 | A Study to Examine the Safety of Different Doses of BG-68501 Given to Participants With Advanced-Stage Tumors | RECRUITING | — |
| NCT06582849 | Enhanced Assistance During Radiotherapy for Unmet Essential Needs | COMPLETED | NA |
| NCT02669914 | MEDI4736 (Durvalumab) in Patients With Brain Metastasis From Epithelial-derived Tumors | TERMINATED | PHASE2 |